{"id":59893,"date":"2026-02-24T23:15:06","date_gmt":"2026-02-24T21:15:06","guid":{"rendered":"https:\/\/www.fyb.de\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/"},"modified":"2026-02-24T23:15:06","modified_gmt":"2026-02-24T21:15:06","slug":"nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/","title":{"rendered":"nyra health: \u20ac 20 million in Series A for AI-supported neurotherapy"},"content":{"rendered":"<p>Vienna \u2014 The digi\u00adtal health company nyra health, a leading provi\u00adder of an AI-based plat\u00adform for neuro\u00adlo\u00adgi\u00adcal therapy, announ\u00adces the successful closing of a Series A finan\u00adcing of EUR 20 million. The round is led by Armira Growth, with exis\u00adting inves\u00adtors Welling\u00adton Part\u00adners, Crane Venture Part\u00adners (who manage the invest\u00adments of Mass\u00adMu\u00adtual Ventures) and EVER Pharma parti\u00adci\u00adpa\u00adting again. The capi\u00adtal will be used for inter\u00adna\u00adtio\u00adnal expan\u00adsion, product deve\u00adlo\u00adp\u00adment and the expan\u00adsion of the AI-based neuro\u00adthe\u00adrapy platform.&nbsp;<\/p>\n<p>The core product is the MDR Class IIa-certi\u00adfied <em>\u201cmyReha\u201d<\/em> plat\u00adform, which accor\u00adding to the company is alre\u00adady being used in over 100 neuro\u00adlo\u00adgi\u00adcal clinics. In addi\u00adtion, the appli\u00adca\u00adtion is part of the stan\u00addard care provi\u00added by Deut\u00adsche Renten\u00adver\u00adsi\u00adche\u00adrung and is reim\u00adbur\u00adsed by 28 statu\u00adtory and private health insu\u00adrance compa\u00adnies. More than 40 million insu\u00adred persons thus have access to digi\u00adtal neuro-rehabilitation.&nbsp;<\/p>\n<p>Inte\u00adgra\u00adtion into inpa\u00adti\u00adent and outpa\u00adti\u00adent care proces\u00adses is parti\u00adcu\u00adlarly rele\u00advant for hospi\u00adtal manage\u00adment. nyra health addres\u00adses the frequently criti\u00adci\u00adzed gap in care between discharge from an acute or reha\u00adbi\u00adli\u00adta\u00adtion clinic and outpa\u00adti\u00adent after\u00adcare. The plat\u00adform connects pati\u00adents and health\u00adcare profes\u00adsio\u00adnals digi\u00adtally throug\u00adhout the entire reco\u00advery process. In addi\u00adtion to the \u201cmyReha\u201d therapy soft\u00adware, the offe\u00adring includes the \u201cnyra insights\u201d manage\u00adment system, which maps therapy inten\u00adsity, language deve\u00adlo\u00adp\u00adment and progress data in real time and auto\u00adma\u00adtes docu\u00admen\u00adta\u00adtion processes.&nbsp;<\/p>\n<p><strong>Stron\u00adger impro\u00adve\u00adments in cogni\u00adtive and lingu\u00adi\u00adstic functions&nbsp;<\/strong><\/p>\n<p>Accor\u00adding to the company, a rando\u00admi\u00adzed control\u00adled study shows signi\u00adfi\u00adcantly grea\u00adter impro\u00adve\u00adments in cogni\u00adtive and lingu\u00adi\u00adstic func\u00adtions with addi\u00adtio\u00adnal use of the plat\u00adform compared to stan\u00addard therapy. The multi\u00admo\u00addal AI models analyze pronun\u00adcia\u00adtion, word retrie\u00adval, syntax and seman\u00adtic struc\u00adture as well as reac\u00adtion times and trai\u00adning dyna\u00admics, among other things. The therapy adapts adap\u00adtively to perfor\u00admance level and progress.&nbsp;<\/p>\n<p>In terms of health econo\u00admics, the model addres\u00adses the rising costs of neuro\u00adlo\u00adgi\u00adcal dise\u00ada\u00adses, for exam\u00adple after a stroke or trau\u00adma\u00adtic brain injury. Digi\u00adtal home therapy with real-time feed\u00adback can increase therapy density and at the same time reduce the workload of specia\u00adlists \u2014 a key aspect given the scar\u00adcity of person\u00adnel resour\u00adces in neuro-rehabilitation.&nbsp;<\/p>\n<p>With the finan\u00adcing, nyra health plans to increase its market pene\u00adtra\u00adtion in the DACH region and enter the US market. At the same time, the company is inves\u00adt\u00ading in the further deve\u00adlo\u00adp\u00adment of multi\u00admo\u00addal AI models, inclu\u00adding as part of a funded rese\u00adarch project.&nbsp;<\/p>\n<p>The market is considera\u00adble: neuro\u00adlo\u00adgi\u00adcal dise\u00ada\u00adses cost 65 billion euros a year in Germany alone. The increase in neuro\u00adlo\u00adgi\u00adcal dise\u00ada\u00adses, prima\u00adrily due to the rising average age of the popu\u00adla\u00adtion, offers considera\u00adble growth potential.&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vienna \u2014 The digi\u00adtal health company nyra health, a leading provi\u00adder of an AI-based plat\u00adform for neuro\u00adlo\u00adgi\u00adcal therapy, announ\u00adces the successful closing of a Series A finan\u00adcing of EUR 20 million. The round is led by Armira Growth, with exis\u00adting inves\u00adtors Welling\u00adton Part\u00adners, Crane Venture Part\u00adners (who manage the invest\u00adments of Mass\u00adMu\u00adtual Ventures) and&nbsp;EVER&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":59891,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[1366],"tags":[],"class_list":["post-59893","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>nyra health: \u20ac 20 million in Series A for AI-supported neurotherapy - FYB Financial Yearbook<\/title>\n<meta name=\"description\" content=\"Vienna - The Vienna-based digital health company nyra health has closed a Series A financing round of 20 million euros. The round was led by Armira Growth, with existing investors Wellington Partners, Crane Venture Partners and EVER Pharma participating again. The capital will be used for international expansion, product development and the expansion of the AI-based neurotherapy platform.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"nyra health: \u20ac 20 million in Series A for AI-supported neurotherapy - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Vienna - The Vienna-based digital health company nyra health has closed a Series A financing round of 20 million euros. The round was led by Armira Growth, with existing investors Wellington Partners, Crane Venture Partners and EVER Pharma participating again. The capital will be used for international expansion, product development and the expansion of the AI-based neurotherapy platform.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-24T21:15:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/02\/nyra-health-co-founders-nyrahealth.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"nyra health: \u20ac 20 million in Series A for AI-supported neurotherapy\",\"datePublished\":\"2026-02-24T21:15:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/\"},\"wordCount\":418,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/02\/nyra-health-co-founders-nyrahealth.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/\",\"url\":\"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/\",\"name\":\"nyra health: \u20ac 20 million in Series A for AI-supported neurotherapy - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/02\/nyra-health-co-founders-nyrahealth.jpg\",\"datePublished\":\"2026-02-24T21:15:06+00:00\",\"description\":\"Vienna - The Vienna-based digital health company nyra health has closed a Series A financing round of 20 million euros. The round was led by Armira Growth, with existing investors Wellington Partners, Crane Venture Partners and EVER Pharma participating again. The capital will be used for international expansion, product development and the expansion of the AI-based neurotherapy platform.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/02\/nyra-health-co-founders-nyrahealth.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/02\/nyra-health-co-founders-nyrahealth.jpg\",\"width\":1200,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"nyra health: \u20ac 20 million in Series A for AI-supported neurotherapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"nyra health: \u20ac 20 million in Series A for AI-supported neurotherapy - FYB Financial Yearbook","description":"Vienna - The Vienna-based digital health company nyra health has closed a Series A financing round of 20 million euros. The round was led by Armira Growth, with existing investors Wellington Partners, Crane Venture Partners and EVER Pharma participating again. The capital will be used for international expansion, product development and the expansion of the AI-based neurotherapy platform.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/","og_locale":"en_US","og_type":"article","og_title":"nyra health: \u20ac 20 million in Series A for AI-supported neurotherapy - FYB Financial Yearbook","og_description":"Vienna - The Vienna-based digital health company nyra health has closed a Series A financing round of 20 million euros. The round was led by Armira Growth, with existing investors Wellington Partners, Crane Venture Partners and EVER Pharma participating again. The capital will be used for international expansion, product development and the expansion of the AI-based neurotherapy platform.","og_url":"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2026-02-24T21:15:06+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/02\/nyra-health-co-founders-nyrahealth.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"nyra health: \u20ac 20 million in Series A for AI-supported neurotherapy","datePublished":"2026-02-24T21:15:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/"},"wordCount":418,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/02\/nyra-health-co-founders-nyrahealth.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/","url":"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/","name":"nyra health: \u20ac 20 million in Series A for AI-supported neurotherapy - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/02\/nyra-health-co-founders-nyrahealth.jpg","datePublished":"2026-02-24T21:15:06+00:00","description":"Vienna - The Vienna-based digital health company nyra health has closed a Series A financing round of 20 million euros. The round was led by Armira Growth, with existing investors Wellington Partners, Crane Venture Partners and EVER Pharma participating again. The capital will be used for international expansion, product development and the expansion of the AI-based neurotherapy platform.","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/02\/nyra-health-co-founders-nyrahealth.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/02\/nyra-health-co-founders-nyrahealth.jpg","width":1200,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/nyra-health-e-20-million-in-series-a-for-ai-supported-neurotherapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"nyra health: \u20ac 20 million in Series A for AI-supported neurotherapy"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/59893","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=59893"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/59893\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/59891"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=59893"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=59893"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=59893"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}